November 2025
You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedChugai Pharmaceutical Co... Market Share Analysis for November 2025
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman.
Chugai Pharmaceutical Co., Ltd. (including company regionals)
See more website traffic and engagement information- chugai-pharm.jp
Chugai Pharmaceutical Co., Ltd. Revenue up to November 2025 is > 1B
revenue generated by Chugai Pharmaceutical Co., Ltd. top domains
Chugai Pharmaceutical Co., Ltd. top domains revenue over 3 years
Revenue for Chugai Pharmaceutical Co., Ltd. top domains
Chugai Pharmaceutical Co., Ltd. Stock price in November 2025
Chugai Pharmaceutical Co., Ltd. stock is traded under the ticker #4519. Below you can review Chugai Pharmaceutical Co., Ltd. stock performance in the past 12 months up to November 2025
Total visits to Chugai Pharmaceutical Co., Ltd.'s top domains
Understand Chugai Pharmaceutical Co., Ltd. market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in Chugai Pharmaceutical Co., Ltd.'s top domains
Analyze Chugai Pharmaceutical Co., Ltd. engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on Chugai Pharmaceutical Co., Ltd.'s top domains
See how Chugai Pharmaceutical Co., Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
